Concepedia

Kunihito Asano

KA

Statistics

Publications

4

Citations

90

H-Index

4

Active since

2008

Affiliations

Pharmaceuticals and Medical Devices Agency(Current)

Chiba University

Nagoya City University

Kunihito Asano is an author at Pharmaceuticals and Medical Devices Agency specializing in medicine, clinical trials, and pharmacotherapy.

Top concepts

MedicineEpidemiologyPublic HealthClinical TrialsPharmacotherapyPharmacoepidemiologyPharmacologyGlobal HealthHealth PolicyDrug Discovery

Publications per year

2008–2020

4

Publications

4

Regulatory Challenges in the Review of Data from Global Clinical Trials: The PMDA Perspective

Kunihito Asano, Ayumi Tanaka, Tosiya Sato et al. · Clinical Pharmacology & Therapeutics · 2013 · 42 citations

Clinical Endpoint, Gct Data, New Drug Approval +22

Use of a toxicity factor to explain differences in nephrotoxicity and myelosuppression among the platinum antitumour derivatives cisplatin, carboplatin and nedaplatin in rats

K. Hanada, Kunihito Asano, Takako Nishimura et al. · Journal of Pharmacy and Pharmacology · 2008 · 20 citations · Full text

Platinum Antitumour Derivatives, Pathology, K Hydrolysis +17

Factors Affecting Drug‐Development Strategies in Asian Global Clinical Trials for Drug Approval in Japan

Kunihito Asano, Yoshiaki Uyama, Masahiro Tohkin · Clinical and Translational Science · 2017 · 14 citations · Full text

Genetic Epidemiology, Pharmacotherapy, Pre-clinical Pharmacology +16

Points to Consider for Implementation of the ICH E17 Guideline: Learning from Past Multiregional Clinical Trials in Japan

Kunihito Asano, Yoko Aoi, Shuji Kamada et al. · Clinical Pharmacology & Therapeutics · 2020 · 14 citations · Full text

E17 Guideline, Preclinical Therapeutics, Clinical Endpoint +23

1–4 of 4